Relationship of asymmetric dimethylarginine with penile doppler ultrasound parameters in men with vasculogenic erectile dysfunction

European Urology

Volumn 59, Issue 6, 2011, Pages 948-955

  Ioakeimidis, Nikolaos ^a   Vlachopoulos, Charalambos ^a   Rokkas, Konstantinos ^a   Aggelis, Athanasios ^a   Terentes Printzios, Dimitrios ^a   Samentzas, Alexios ^a   Alexopoulos, Nikolaos ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Asymmetric dimethylarginine; Dynamic penile Doppler ultrasound; Endothelial dysfunction; Erectile dysfunction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; TESTOSTERONE;

ADULT; AGED; ARTERIAL INSUFFICIENCY; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE MARKER; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PATHOPHYSIOLOGY; PENILE BLOOD FLOW; PENIS DISEASE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTOLE; VASCULAR DISEASE; VEIN OCCLUSION;

ADULT; AGED; ANALYSIS OF VARIANCE; ARGININE; ARTERIES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; GREECE; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PENILE ERECTION; PENIS; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, COLOR; UP-REGULATION; VEINS;

EID: 79955574239     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.02.008     Document Type: Article

References (43)

1. Y. Vardi, L. Dayan, B. Apple, I. Gruenwald, Y. Ofer, and G. Jacob Penile and systemic endothelial function in men with and without erectile dysfunction Eur Urol 55 2009 979 985
2. T.J. Bivalacqua, T. Liu, B. Musicki, H.C. Champion, and A.L. Burnett Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis Eur Urol 51 2007 1732 1740 (Pubitemid 46634738)
3. C. Vlachopoulos, N. Ioakeimidis, and D. Terentes-Printzios Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of vasculogenic erectile dysfunction Eur Urol 56 2009 552 558
4. C. Vlachopoulos, N. Ioakeimidis, D. Terentes-Printzios, and C. Stefanadis The triad: erectile dysfunction - endothelial dysfunction - cardiovascular disease Curr Pharm Des 14 2008 3700 3714
5. E. Chiurlia, R. D'Amico, C. Ratti, A. Granata, R. Romagnoli, and M. Modena Subclinical coronary artery atherosclerosis in patients with erectile dysfunction J Am Coll Cardiol 46 2005 1503 1506 (Pubitemid 41446186)
6. P. Montorsi, P.M. Ravagnani, and S. Galli Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial Eur Heart J 22 2006 2632 2639 (Pubitemid 44729861)
7. P. Montorsi, P.M. Ravagnani, and S. Galli Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient Eur Urol 50 2006 721 731 (Pubitemid 44332685)
8. C. Vlachopoulos, K. Rokkas, and N. Ioakeimidis Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study Eur Urol 48 2005 996 1003
9. I.M. Thompson, C.M. Tangen, P.J. Goodman, J.L. Probstfield, C.M. Moinpour, and C.A. Coltman Erectile dysfunction and subsequent cardiovascular disease JAMA 294 2005 2996 3002 (Pubitemid 41817661)
10. M. Böhm, M. Baumhäkel, K. Teo ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials Circulation 121 2010 1439 1446
11. A.B. Araujo, S.A. Hall, and P. Ganz Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 55 2010 26 350 356
12. J.P. Cooke Asymmetrical dimethylarginine: the uber marker? Circulation 109 2004 1813 1818
13. R.H. Böger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 2003 824 833 (Pubitemid 38366238)
14. R. Maas, V. Xanthakis, and J.F. Polak Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort Stroke 40 2009 2715 2719
15. R.H. Böger, L.M. Sullivan, and E. Schwedhelm Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community Circulation 119 2009 1592 1600
16. R. Maas, E. Schwedhelm, J. Albsmeier, and R.H. Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vasc Med 7 2002 213 225 (Pubitemid 36104323)
17. A. Wierzbicki, H. Solomon, P. Lumb, K. Lyttle, M. Lambert-Hammill, and G. Jackson Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction Atherosclerosis 185 2006 421 425
18. C. Vlachopoulos, K. Aznaouridis, and N. Ioakeimidis Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction J Hypertens 26 2008 1829 1836
19. R. Maas, S. Wenske, and M. Zabel Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction Eur Urol 48 2005 1004 1012
20. A.A. Elesber, H. Solomon, and R.J. Lennon Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis Eur Heart J 27 2006 824 831
21. T. Aktoz, M. Aktoz, and E. Tatli Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease Int Urol Nephrol 42 2010 873 879
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
23. A. Aversa, and L.M. Sarteschi The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction J Sex Med 4 2007 1437 1447 (Pubitemid 47337692)
24. K.L. Billups, D.R. Kaiser, and A.S. Kelly Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction Int J Impot Res 15 2003 231 236 (Pubitemid 37101655)
25. H. Masuda, T. Tsujii, T. Okuno, K. Kihara, M. Goto, and H. Azuma Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia Am J Physiol Regul Integr Comp Physiol 282 2002 R1730 R1738
26. K. Park, D. Lee, S. Kim, and J. Paick Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis Int J Impot Res 21 2009 228 234
27. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
28. D.R. Kaiser, K. Billups, C. Mason, R. Wetterling, J.L. Lundberg, and A.J. Bank Impaired brachial artery endothelium-dependent and - independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease J Am Coll Cardiol 43 2004 179 184 (Pubitemid 38201141)
29. H. Päivä, M. Kähönen, and T. Lehtimäki Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study Atherosclerosis 212 2010 512 515
30. R. Maas, K. Quitzau, and E. Schwedhelm Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia Atherosclerosis 191 2007 211 221
31. S. Takiuchi, H. Fujii, and K. Kamide Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients Am J Hypertens 17 2004 802 808 (Pubitemid 39201096)
32. R.C. Dean, and T.F. Lue Physiology of penile erection and pathophysiology of erectile dysfunction Urol Clin North Am 32 2005 379 395 (Pubitemid 41607527)
33. V. Mirone, C. Imbimbo, F. Fusco, P. Verze, M. Creta, and G. Tajana Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? Eur Urol 56 2009 309 316
34. E. Cakir, O. Ozcan, and H. Yaman Elevated plasma concentration of asymmetric dimethylarginine that is reduced by single dose testosterone administration in idiopathic hypogonadotropic hypogonadism patients J Clin Endocrinol Metab 90 2005 1651 1654 (Pubitemid 40464033)
35. P. Montorsi, F. Montorsi, and C.C. Schulman Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? Eur Urol 44 2003 352 354 (Pubitemid 37051705)
36. K. Furuki, H. Adachi, and H. Matsuoka Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study Atherosclerosis 191 2007 206 210 (Pubitemid 46227419)
37. C. Iribarren, G. Husson, K. Sydow, B.Y. Wang, S. Sidney, and J.P. Cooke Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study Eur J Cardiovasc Prev Rehabil 14 2007 222 229 (Pubitemid 46650077)
38. K. Krzyzanowska, F. Mittermayer, and W. Krugluger Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type diabetes Atherosclerosis 189 2006 236 240 (Pubitemid 44441289)
39. A.M. Wilson, D.S. Shin, and C. Weatherby Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease Vasc Med 15 2010 267 274
40. C. Napoli, V. Sica, and F. de Nigris Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension Am Heart J 148 2004 e5
41. J. Chen, Y. Wollman, T. Chernichovsky, A. Iaina, M. Sofer, and H. Matzkin Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study BJU Int 83 1999 269 273 (Pubitemid 29151525)
42. R. Maas Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA) Vasc Med 10 2005 S49 57
43. S. Deveci, K. O'Brien, A. Ahmed, M. Parker, P. Guhring, and J.P. Mulhall Can the International Index of Erectile Function distinguish between organic and psychogenic erectile function? BJU Int 102 2008 354 356 (Pubitemid 352019193)